Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01290562
Other study ID # UHN REB 10-0540-C
Secondary ID
Status Completed
Phase Phase 2
First received February 3, 2011
Last updated May 2, 2017
Start date June 2011
Est. completion date April 27, 2017

Study information

Verified date May 2017
Source University Health Network, Toronto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with new or recurrent spine metastases are currently treated with low doses of radiation delivered in up to ten treatments (wide-field radiation therapy). Stererotactic body radiotherapy (SBRT) is a technique in which high doses of radiation targeted precisely to the metastases to be treated are administered in a small number of sessions, thus reducing the radiation damage to the surrounding tissue and areas of the spine.

The purpose of this study is to evaluate the efficacy of spine SBRT as an alternative to conventional radiation for patients with no prior radiation, prior radiation, and in the post-operative patient


Description:

Spine SBRT is currently being practiced as an alternative to conventional wide-field radiation in the up-front management of spinal metastases, in the re-irradiation scenario, and in the post-operative setting. This study proposes to treat patients with a uniform spine SBRT approach, and collect prospective outcome data as a basis for future randomized trial design. Preliminary evaluation of our technique has yielded acceptable accuracy in treatment delivery as compared to the literature, and our practice follows current standards in major university hospitals performing this technique. Furthermore, preliminary data also suggest efficacy and safety for patients treated with SBRT for spinal metastases in a previously radiated field. However, well defined prospective outcomes are lacking in this patient group.

There a 3 cohorts for this study each with a target accrual of 30 patients. Cohort 1: patients with spinal metastases and no prior radiation.

Cohort 2: patients with spinal metastases with a history of previous radiation to the affected spinal segment.

Cohort 3: post-operative patients with spinal metastases with or without a history of previous radiation to the affected spinal segment.

All patients will be treated with either 20-24 Gy in one fraction (recommended) or 20-24 Gy in two fractions, or 20-24 Gy in three fractions. There is also and optional imaging component of this study.

The purpose of the study is to determine the efficacy of spine SBRT in select groups of patients using image based and symptom based local control criteria


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date April 27, 2017
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria:

- Solitary or oligometastatic spine disease (maximum 5 sites of metastases), or bone only metastatic disease (regardless of the number) in otherwise high performance status patients, or patients with diffuse metastatic disease where the patient survival is expected to be at least 6 months

- Maximum of 2 consecutive spinal segments involved by tumor for treatment otherwise a maximum of 3 sites within the spine to be treated in a single session

- Previously irradiated: up to one course where the maximum BED previously delivered is no more than 100 Gy2 (50 Gy2/2) and >5 month interval from prior radiation to planned SBRT (Cohort 2) or first part of cohort 3

- Karnofsky Performance Status >60

- Had an MRI or CT documented spinal tumor and MRI of full spine no more than 8 weeks prior to SBRT (if patients cannot have a MRI then a CT myelogram is required)

- Had a histological confirmation of neoplastic disease

- Expected to have survival of > 3 months regardless of the number of metastases

- Able to lie still and in a supine position on the treatment couch for up to 1 hour

- Age >18

- Adequate Bowel or urinary function

Exclusion Criteria:

- A Pacemaker such that MRI cannot be performed or the treatment cannot be delivered safely

- Scleroderma or connective tissue disease as a contra-indication to radiotherapy

- Unable to lie supine (i.e. tolerate treatment)

- Previously treated with any radionuclides within 30 days prior to SBRT

- Had external beam radiotherapy to the same area less than 5 months prior to SBRT and/or a course of radiation previously delivered >100 Gy2 (50 Gy2/2)

- Significant or progressive neurologic deficit

- Malignant epidural spinal cord compression or cauda equina syndrome

- Spine instability, or neurological deficit resulting from bony compression of neural structures

- Receiving chemotherapy for at least 1 week prior to SBRT and chemotherapy for one week following SBRT

- Expected patient survival < 3 months

Study Design


Intervention

Radiation:
Stereotactic Body Radiotherapy (SBRT)
One or more high dose(s) of radiation to treat the tumour.

Locations

Country Name City State
Canada University Health Network, Princess Margaret Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine the efficacy of spine SBRT in select groups of patients using image based and symptom based local control criteria 5 years
Secondary To determine prospective pain and functional outcome data using the Brief Pain Inventory questionnaire 5 years
Secondary To prospectively document quality of life outcomes for patients post-SBRT using the validated EORTC QLQ - BM22 and C-15 PAL 5 years
Secondary To determine pain flare prospective data by using the Pain Diary for first 10 days after radiation. 5 years
Secondary To prospectively evaluate neurologic outcomes using the ASIA questionnaire 5 years
Secondary To evaluate acute and late toxicity of RT using NCIC Common Toxicity Criteria v. 3.0 5 years
See also
  Status Clinical Trial Phase
Completed NCT01347307 - Stereotactic Body Radiotherapy for Spine Tumors N/A
Terminated NCT00593320 - Stereotactic Radiosurgery (SRS) for Spine Metastases N/A
Recruiting NCT05575323 - Randomized Trial on Same-day SBRT and Surgical Stabilization for Symptomatic Spinal Metastases N/A
Completed NCT02987153 - Kypho-Intra Operative Radiation Therapy (IORT) for Localized Spine Metastasis, Phase I/II Study N/A
Recruiting NCT03363685 - Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal Metastasis
Terminated NCT02407795 - Conventional With Stereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal Metastases N/A
Completed NCT01365715 - Preoperative Embolization in Surgical Treatment of Spinal Metastases. N/A
Recruiting NCT04863612 - SBRT in the Management of Solid Spinal Metastases
Recruiting NCT04242589 - Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions Phase 2
Recruiting NCT01849510 - Efficacy of Dose Intensified Radiotherapy of Spinal Metastases by Hypofractionated Radiation and IGRT hfSRT Mediated Boost Phase 2
Not yet recruiting NCT06244264 - The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis N/A
Not yet recruiting NCT06220071 - Multicentric European Study In Patients With Vertebral Metastases
Recruiting NCT06120426 - En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.
Completed NCT03224650 - Validation of Novel Predictive Score for Patients With Spinal Metastases
Completed NCT02512965 - Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases N/A
Not yet recruiting NCT06093854 - Intraoperative Radiotherapy in Treating Spinal Metastases N/A
Completed NCT02364115 - Randomized Trial Comparing Conventional Radiotherapy With Stereotactic Radiotherapy in Patients With Bone Metastases - VERTICAL Study N/A
Recruiting NCT03398915 - The European Robotic Spinal Instrumentation (EUROSPIN) Study
Not yet recruiting NCT05173467 - Robot-assisted Invasion-controlled Surgery Versus Traditional-open Surgery Against Metastatic Spinal Tumor N/A
Recruiting NCT04248543 - Quantitative MRI for Functional Assessment Following SBRT for Spinal Metastases N/A